This inventor holds 1 USPTO granted patent and 2 published patent applications, plus 1 CIPO patent. Top assignees: Daewoong Pharmaceutical Co., Ltd., Daewoong Therapeutics Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 5 
1 out of 1 Years Active: 2026
Title: Sanghan Park: Patent Activity in Pharmaceutical Innovation.
Introduction
Sanghan Park is an inventor associated with Seoul, South Korea. The supplied information lists one patent for Park, focused on a delayed-release formulation of niclosamide and its antiviral use.
Latest Patents
Park’s listed patent is “Niclosamide Delayed-Release Composition and Antiviral Use Thereof.” The invention concerns a pharmaceutical composition designed for delayed release and its potential application in antiviral treatment. The supplied data identifies 1 patent and does not provide filing or publication dates.
Career Highlights
The supplied information associates Park with Daewoong Therapeutics Inc. and Daewoong Pharmaceutical Co., Ltd. These affiliations place Park’s listed patent activity in the pharmaceutical sector.
Collaborations
Bokki Kang and Minsuk Lee are identified as Park’s coworkers. The available information does not specify their roles in the patent or related research.
Conclusion
Sanghan Park’s listed work centers on a niclosamide delayed-release composition and its antiviral use, with reported professional affiliations in pharmaceutical companies and connections to coworkers Bokki Kang and Minsuk Lee.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile